Latest Breaking News On - Pearsanta inc - Page 2 : comparemela.com

Liquid Biopsy in Cancer Diagnostics Global Market is Likely to Increase at a Massive Growth Rate of ~17% by 2028

/PRNewswire/ DelveInsight s Liquid Biopsy in Cancer Diagnostics Market Insights report provides the current and forecast market analysis, individual leading.

United statesShruti thakurPrnewswire delveinsightB braun melsungenExai bioDaiichi sankyoCardinal healthAngle plcAgilent technologies incMenarini groupBoston scientific corporationAbbvie incMarket researchGenetics incHologic incNational coverage

Aditxt, Inc s Subsidiary Pearsanta, Inc Acquires MDNA Life Sciences Inc s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million -January 08, 2024 at 08:37 am EST

This strategic acquisition positions Pearsanta for robust growth: expanding opportunities in women’s health, spanning endometriosis to ovarian cancer, and in men’s health starting with prostate.

United statesChris mittonAmro albannaErnie leeExchange commissionLife sciences incAmerican cancer societyEvofem biosciences incPearsanta incAditxt incWorld health organizationPrecision medicineMitomic endometriosis testMitomic prostate testVast opportunitiesEarly cancer

InvestorNewsBreaks – Aditxt Inc (NASDAQ: ADTX), Subsidiary Pearsanta Announce Acquisition of MDNA Life Sciences Inc s Mitomic(TM) Testing Platform

InvestorNewsBreaks – Aditxt Inc (NASDAQ: ADTX), Subsidiary Pearsanta Announce Acquisition of MDNA Life Sciences Inc s Mitomic(TM) Testing Platform
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ernie leeLos angelesAditxt incPearsanta incAdimune tm incPearsanta tm incLife sciences incAdivir tm incMitomic endometriosis testMitomic prostate testDynamic brand portfolio

Aditxt Announces Closing of $6 0 Million Private Placement Priced At-The-Market under Nasdaq Rules

Aditxt, Inc. , an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has closed its previously.

United statesHc wainwright coPearsanta incAditxt incAdivir incAdimune incExchange commissionSecurities actPromising innovations possibleAnnual report

Aditxt Announces $6 Million Private Placement Priced At-The-Market under Nasdaq Rules

Aditxt Announces $6 Million Private Placement Priced At-The-Market under Nasdaq Rules
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesExchange commissionAditxt incAdimune incHc wainwright coAdivir incPearsanta incSecurities actPromising innovations possibleAnnual report